Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives

被引：23

作者：

Bouligny, Ian M. ^{[1
]}

Maher, Keri R. ^{[1
]}

Grant, Steven ^{[1
]}

机构：

[1] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA

来源：

BLOOD REVIEWS | 2023年 / 57卷

关键词：

Acute myeloid leukemia; Leukemogenesis; Epigenetics; Transcription factor; Oncoprotein; Signal transduction; Cell cycle; Novel strategies; Targeted therapy; CORE-BINDING-FACTOR; HEMATOPOIETIC STEM-CELLS; ACUTE MYELOGENOUS LEUKEMIA; HISTONE DEACETYLASE INHIBITORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; DNA METHYLATION; C/EBP-ALPHA; PROGNOSTIC RELEVANCE; GENE-EXPRESSION;

D O I：

10.1016/j.blre.2022.100996

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute myeloid leukemia (AML) is a heterogeneous hematopoietic neoplasm which results in clonal proliferation of abnormally differentiated hematopoietic cells. In this review, mechanisms contributing to myeloid leukemogenesis are summarized, highlighting aberrations of epigenetics, transcription factors, signal transduction, cell cycling, and the bone marrow microenvironment. The mechanisms contributing to AML are detailed to spotlight recent findings that convey clinical impact. The applications of current and prospective therapeutic targets are accentuated in addition to reviews of treatment paradigms stratified for each characteristic molecular lesion - with a focus on exploring novel treatment approaches and combinations to improve outcomes in AML.

引用

页数：17

共 260 条

[1] ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression [J].

Abdel-Wahab, Omar ;

Adli, Mazhar ;

LaFave, Lindsay M. ;

Gao, Jie ;

Hricik, Todd ;

Shih, Alan H. ;

Pandey, Suveg ;

Patel, Jay P. ;

Chung, Young Rock ;

Koche, Richard ;

Perna, Fabiana ;

Zhao, Xinyang ;

Taylor, Jordan E. ;

Park, Christopher Y. ;

Carroll, Martin ;

Melnick, Ari ;

Nimer, Stephen D. ;

Jaffe, Jacob D. ;

Aifantis, Iannis ;

Bernstein, Bradley E. ;

Levine, Ross L. .

CANCER CELL, 2012, 22 (02) :180-193

[2] The leukemic protein core binding factor β (CBFβ)-smooth-muscle myosin heavy chain sequesters CBFα2 into cytoskeletal filaments and aggregates [J].

Adya, N ;

Stacy, T ;

Speck, NA ;

Liu, PP .

MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :7432-7443

[3] An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1 [J].

Al-Harbi, Sayer ;

Aljurf, Mahmoud ;

Mohty, Mohamad ;

Almohareb, Fahad ;

Ahmed, Syed Osman Ali .

BLOOD ADVANCES, 2020, 4 (01) :229-238

[4] C/EBRγ deregulation results in differentiation arrest in acute myeloid leukemia [J].

Alberich-Jorda, Meritxell ;

Wouters, Bas ;

Balastik, Martin ;

Shapiro-Koss, Clara ;

Zhang, Hong ;

DiRuscio, Annalisa ;

Radomska, Hanna S. ;

Ebralidze, Alexander K. ;

Amabile, Giovanni ;

Ye, Min ;

Zhang, Junyan ;

Lowers, Irene ;

Avellino, Roberto ;

Melnick, Ari ;

Figueroa, Maria E. ;

Valk, Peter J. M. ;

Delwel, Ruud ;

Tenen, Daniel G. .

JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (12) :4490-4504

[5] Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response [J].

Amatangelo, Michael D. ;

Quek, Lynn ;

Shih, Alan ;

Stein, Eytan M. ;

Roshal, Mikhail ;

David, Muriel D. ;

Marteyn, Benoit ;

Farnoud, Noushin Rahnamay ;

de Botton, Stephane ;

Bernard, Olivier A. ;

Wu, Bin ;

Yen, Katharine E. ;

Tallman, Martin S. ;

Papaemmanuil, Elli ;

Penard-Lacronique, Virginie ;

Thakurta, Anjan ;

Vyas, Paresh ;

Levine, Ross L. .

BLOOD, 2017, 130 (06) :732-741

[6] Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis [J].

Asada, Shuhei ;

Goyama, Susumu ;

Inoue, Daichi ;

Shikata, Shiori ;

Takeda, Reina ;

Fukushima, Tsuyoshi ;

Yonezawa, Taishi ;

Fujino, Takeshi ;

Hayashi, Yasutaka ;

Kawabata, Kimihito Cojin ;

Fukuyama, Tomofusa ;

Tanaka, Yosuke ;

Yokoyama, Akihiko ;

Yamazaki, Satoshi ;

Kozuka-Hata, Hiroko ;

Oyama, Masaaki ;

Kojima, Shinya ;

Kawazu, Masahito ;

Mano, Hiroyuki ;

Kitamura, Toshio .

NATURE COMMUNICATIONS, 2018, 9

[7] Contribution of bone microenvironment to leukemogenesis and leukemia progression [J].

Ayala, F. ;

Dewar, R. ;

Kieran, M. ;

Kalluri, R. .

LEUKEMIA, 2009, 23 (12) :2233-2241

[8] Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients [J].

Bacher, Ulrike ;

Haferlach, Claudia ;

Kern, Wolfgang ;

Haferlach, Torsten ;

Schnittger, Susanne .

BLOOD, 2008, 111 (05) :2527-2537

[9] Differential expression of Sonic hedgehog and Gli1 in hematological malignancies [J].

Bai, L-Y ;

Chiu, C-F ;

Lin, C-W ;

Hsu, N-Y ;

Lin, C-L ;

Lo, W-J ;

Kao, M-C .

LEUKEMIA, 2008, 22 (01) :226-228

[10] Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex [J].

Balasubramani, Anand ;

Larjo, Antti ;

Bassein, Jed A. ;

Chang, Xing ;

Hastie, Ryan B. ;

Togher, Susan M. ;

Lahdesmaki, Harri ;

Rao, Anjana .

NATURE COMMUNICATIONS, 2015, 6

← 1 2 3 4 5 6 7 8 9 10 →